Clinical trial
Lendormin D® Tablet (Drug Use Result Survey)
NCT02224014 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lendormin D® Tablet (Drug Use Result Survey)
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2005
- Completion date
- Not reported
- Enrollment
- 485 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.